These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29666651)

  • 21. The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?
    Ozen G; Sunbul M; Atagunduz P; Direskeneli H; Tigen K; Inanc N
    Rheumatology (Oxford); 2016 Mar; 55(3):513-22. PubMed ID: 26472565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propensity score matching/reweighting analysis comparing intravenous golimumab to infliximab for ankylosing spondylitis using data from the GO-ALIVE and ASSERT trials.
    Gensler LS; Chakravarty SD; Cameron C; Peterson S; Spin P; Kafka S; Nair S; Deodhar A
    Clin Rheumatol; 2020 Oct; 39(10):2907-2917. PubMed ID: 32367407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclinical Atherosclerosis Is Not Accelerated in Patients with Ankylosing Spondylitis with Low Disease Activity: New Data and Metaanalysis of Published Studies.
    Arida A; Protogerou AD; Konstantonis G; Konsta M; Delicha EM; Kitas GD; Sfikakis PP
    J Rheumatol; 2015 Nov; 42(11):2098-105. PubMed ID: 26428207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of lipid profiles in patients with metabolic syndrome according to cardiovascular risk calculated on the basis of the SCORE chart.
    Gierach M; Gierach J; Junik R
    Endokrynol Pol; 2016; 67(3):265-70. PubMed ID: 26884291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy.
    van der Valk FM; Bernelot Moens SJ; Verweij SL; Strang AC; Nederveen AJ; Verberne HJ; Nurmohamed MT; Baeten DL; Stroes ES
    Ann Rheum Dis; 2016 Oct; 75(10):1848-51. PubMed ID: 27084958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between C-reactive protein rs3091244 polymorphism and ankylosing spondylitis.
    Akbal A; Reşorlu H; Gökmen F; Savaş Y; Zateri Ç; Sargin B; Bozkurt E; Sılan F; Özdemir Ö
    Int J Rheum Dis; 2016 Jan; 19(1):43-8. PubMed ID: 26480896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease.
    Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Miranda-Filloy JA; Dierssen T; Vaqueiro I; Blanco R; Martin J; Llorca J; Gonzalez-Gay MA
    Medicine (Baltimore); 2009 Nov; 88(6):358-365. PubMed ID: 19910750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study.
    Nam B; Koo BS; Lee TH; Shin JH; Kim JJ; Lee S; Joo KB; Kim TH
    BMC Musculoskelet Disord; 2021 Feb; 22(1):140. PubMed ID: 33541326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment.
    Andrés M; Bernal JA; Sivera F; Quilis N; Carmona L; Vela P; Pascual E
    Ann Rheum Dis; 2017 Jul; 76(7):1263-1268. PubMed ID: 28093417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors.
    Rosales Alexander JL; Cantero-Hinojosa J; Salvatierra J; Magro Checa C; González-Gay MÁ; Raya Álvarez E
    Joint Bone Spine; 2014 Mar; 81(2):164-8. PubMed ID: 23932927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A study on calculating the ankylosing spondylitis disease activity score according to the C-reactive protein level].
    Ji X; Du J; Zhu J; Huang F; Zhang J
    Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):206-10. PubMed ID: 26926373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study.
    Ferraz-Amaro I; Corrales A; Atienza-Mateo B; Vegas-Revenga N; Prieto-Peña D; Blanco R; González-Gay MÁ
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carotid ultrasound in the cardiovascular risk stratification of patients with rheumatoid arthritis: when and for whom?
    González-Gay MA; González-Juanatey C; Llorca J
    Ann Rheum Dis; 2012 Jun; 71(6):796-8. PubMed ID: 22562981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients.
    Bansal N; Duggal L; Jain N
    J Clin Diagn Res; 2017 Sep; 11(9):OC06-OC09. PubMed ID: 29207750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis.
    Gómez-Vaquero C; Corrales A; Zacarías A; Rueda-Gotor J; Blanco R; González-Juanatey C; Llorca J; González-Gay MA
    Arthritis Res Ther; 2013 Aug; 15(4):R91. PubMed ID: 23965231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reclassification into very-high cardiovascular risk after carotid ultrasound in patients with axial spondyloarthritis.
    Rueda-Gotor J; Quevedo-Abeledo JC; Corrales A; Genre F; Hernández-Hernández V; Delgado-Frías E; González-Gay MÁ; Ferraz-Amaro I
    Clin Exp Rheumatol; 2020; 38(4):724-731. PubMed ID: 32083538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of serum asymmetric dimethylarginine levels and left ventricular diastolic function in patients with ankylosing spondylitis.
    Inci U; Yildiz A; Batmaz I; Tekbas E
    Int J Rheum Dis; 2017 Feb; 20(2):238-244. PubMed ID: 26012572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.